Taki M[au] - Search Results

Year	Number of Results
1963	1
1965	1
1970	2
1972	2
1976	1
1977	2
1979	1
1980	1
1981	2
1982	4
1983	4
1984	1
1985	2
1986	3
1987	2
1988	7
1989	1
1990	3
1991	8
1993	3
1994	3
1995	1
1996	5
1997	4
1998	9
1999	8
2000	13
2001	13
2002	8
2003	18
2004	21
2005	14
2006	26
2007	15
2008	21
2009	25
2010	14
2011	25
2012	16
2013	25
2014	18
2015	18
2016	25
2017	28
2018	25
2019	28
2020	21
2021	30
2022	25

1

Tumor Immune Microenvironment during Epithelial-Mesenchymal Transition.

Taki M, Abiko K, Ukita M, Murakami R, Yamanoi K, Yamaguchi K, Hamanishi J, Baba T, Matsumura N, Mandai M. Taki M, et al. Clin Cancer Res. 2021 Sep 1;27(17):4669-4679. doi: 10.1158/1078-0432.CCR-20-4459. Epub 2021 Apr 7. Clin Cancer Res. 2021. PMID: 33827891 Review.

2

Snail promotes ovarian cancer progression by recruiting myeloid-derived suppressor cells via CXCR2 ligand upregulation.

Taki M, Abiko K, Baba T, Hamanishi J, Yamaguchi K, Murakami R, Yamanoi K, Horikawa N, Hosoe Y, Nakamura E, Sugiyama A, Mandai M, Konishi I, Matsumura N. Taki M, et al. Nat Commun. 2018 Apr 27;9(1):1685. doi: 10.1038/s41467-018-03966-7. Nat Commun. 2018. PMID: 29703902 Free PMC article.

3

A multicentre, open-label study of emicizumab given every 2 or 4 weeks in children with severe haemophilia A without inhibitors.

Shima M, Nogami K, Nagami S, Yoshida S, Yoneyama K, Ishiguro A, Suzuki T, Taki M. Shima M, et al. Among authors: taki m. Haemophilia. 2019 Nov;25(6):979-987. doi: 10.1111/hae.13848. Epub 2019 Sep 12. Haemophilia. 2019. PMID: 31515851 Free PMC article. Clinical Trial.

4

Newborn Screening for Severe Combined Immunodeficiency.

Taki M, Miah T, Secord E. Taki M, et al. Immunol Allergy Clin North Am. 2021 Nov;41(4):543-553. doi: 10.1016/j.iac.2021.07.007. Immunol Allergy Clin North Am. 2021. PMID: 34602227 Review.

5

B7-H3 Suppresses Antitumor Immunity via the CCL2-CCR2-M2 Macrophage Axis and Contributes to Ovarian Cancer Progression.

Miyamoto T, Murakami R, Hamanishi J, Tanigaki K, Hosoe Y, Mise N, Takamatsu S, Mise Y, Ukita M, Taki M, Yamanoi K, Horikawa N, Abiko K, Yamaguchi K, Baba T, Matsumura N, Mandai M. Miyamoto T, et al. Among authors: taki m. Cancer Immunol Res. 2022 Jan;10(1):56-69. doi: 10.1158/2326-6066.CIR-21-0407. Epub 2021 Nov 19. Cancer Immunol Res. 2022. PMID: 34799346

6

Newborn Screening for Severe Combined Immunodeficiency.

Taki M, Miah T, Secord E. Taki M, et al. Pediatr Clin North Am. 2019 Oct;66(5):913-923. doi: 10.1016/j.pcl.2019.06.007. Pediatr Clin North Am. 2019. PMID: 31466681 Review.

7

Imaging and sensing of cadmium in cells.

Taki M. Taki M. Met Ions Life Sci. 2013;11:99-115. doi: 10.1007/978-94-007-5179-8_5. Met Ions Life Sci. 2013. PMID: 23430772 Free article. Review.

8

Low-Frequency Sensorineural Hearing Loss Associated With Iron-Deficiency Anemia.

Taki M, Hasegawa T, Ninoyu Y, Mohri H, Hirano S. Taki M, et al. J Int Adv Otol. 2021 Sep;17(5):465-467. doi: 10.5152/iao.2021.9369. J Int Adv Otol. 2021. PMID: 34617900 Free PMC article.

9

Acquired Evolution of Mitochondrial Metabolism Regulated by HNF1B in Ovarian Clear Cell Carcinoma.

Yamaguchi K, Kitamura S, Furutake Y, Murakami R, Yamanoi K, Taki M, Ukita M, Hamanishi J, Mandai M. Yamaguchi K, et al. Among authors: taki m. Cancers (Basel). 2021 May 17;13(10):2413. doi: 10.3390/cancers13102413. Cancers (Basel). 2021. PMID: 34067626 Free PMC article. Review.

10

Hepatocyte growth factor predicts failure of Fontan circulation.

Kojima T, Taki M, Toda K, Muraji S, Yoshiba S, Kobayshi T, Sumitomo N. Kojima T, et al. Among authors: taki m. ESC Heart Fail. 2020 Sep 10;7(6):3738-44. doi: 10.1002/ehf2.12943. Online ahead of print. ESC Heart Fail. 2020. PMID: 32914543 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results